Company Name: Xencor, Inc.   

Xencor, Inc. a clinical-stage biopharmaceutical company. The company is engaged in the development of engineered monoclonal antibodies designed to treat asthma and allergic diseases, autoimmune disorders and cancer. The company’s lead product candidates include treatments for:

• Acute lymphoblastic leukemia and non-Hodgkin lymphoma (licensed to Morphosys AG)
• Asthma and allergic diseases
• Rheumatoid arthritis

Ticker Symbol: XNCR (NASDAQ)

Company Website: www.xencor.com

Social Media: Xencor LinkedIn

Headquarters: Monrovia, CA